Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
- Clinicians are starting to become aware of the advantages of liquid biopsy, but they still have reservations. The point is, clinicians are unlikely to be moved by superficial appeals to technological progress. They will not fully accept liquid biopsy until they see substantive demonstrations that the sample-collecting method offers unique benefits to patients, without depriving them of any of the benefits that are already available with traditional biopsy techniques.